Skip to content
TickerMagic

IOL Chemicals and Pharmaceuticals Limited

IOLCPNSEHealthcare
₹191.78
+2.04 (+1.08%) · EOD 2026-11-20

Our verdict

Buy

Financial trend (87/100) does the heavy lifting; quality (54/100) is the drag.

Buy zoneHealth A
Quality 54Momentum 64Value 78Trend 87The Spark ↓

Our fair value

Undervalued by 16%
₹222.15up 15.84%
Price ₹192Range ₹96 – ₹291

Buy-below (20% margin of safety): ₹177.72

The bottom line

TickerMagic rates IOL Chemicals and Pharmaceuticals Limited a Buy, scoring 70/100 on our blended model. At ₹191.78 it trades below our blended DCF and relative-multiples fair value of ₹222.15, about 16% upside to that estimate — we read it as undervalued by 16%. On 28.0x trailing earnings it sits cheaper than the Healthcare median of about 37.4x. The price is about 13% below its 52-week high of ₹220.22 and 181% above the low of ₹68.15. Financial health scores 96/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9. The average analyst target of ₹150 implies about 22% downside across 1 analysts. It clears 7 of 13 investability checks, with durability 54, valuation 80 and momentum 64 on our 0–100 scales.

Analysis by Ankit Sharma · TickerMagic's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.

Intrinsic value
Our fair value
₹222.15up 15.84%
Undervalued by 16%
Price ₹191.78Range ₹95.89–₹291.4
DCF + relative blendhigh confidence

With a 20% margin of safety, our buy-below price is ₹177.72.

Analyst views

1 analysts1 buy · 0 hold · 0 sell
12-month consensus target₹150down 21.79%

1-year price

EOD · 2026-11-20
1D
up 1.08%
1W
down 6.49%
1M
up 4.72%
3M
up 20.47%
6M
up 74.16%
1Y
—

52-week range

-12.91% from the 52-week high.

Trend check
Below 50-DMA₹195Above 200-DMA₹137

Price above both moving averages reads as an intact uptrend; below both, the trend is against you.

Verdict pillars

Buy70
A
Financial health 96/100
Altman Z 4.83 · Safe zone

Piotroski F-score 5/9 — quality of earnings & balance sheet.

Our scores

Durability54
Valuation80
Momentum64

Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.

Investability checklist

Passed 7 of 13 checks
Each check screens one fundamentals, valuation or trend signal.
  • Fail: ROE above 15%: 7.9%
  • Pass: Low debt (D/E < 0.5): 0.08x
  • Fail: Positive free cash flow
  • Pass: Revenue growth > 10%: 17%
  • Pass: Earnings growing: 70%
  • Fail: Net margin ≥ 10%: 5.9%
  • Pass: Current ratio > 1.5: 1.78
  • Pass: Below our fair value
  • Fail: Margin of safety ≥ 20%
  • Pass: Above 200-day average
  • Fail: Above 50-day average
  • No data: Positive 1-year return
  • Pass: Altman Z in safe zone: Z 4.83
  • Fail: Piotroski ≥ 7: 5/9

Quarterly results

Revenue · 4Q2025
₹580 Cr
Net profit
₹29 Cr
Margin
5%
1Q2025
2Q2025
3Q2025
4Q2025
Revenue Net profitLatest revenue QoQ +2%

Annual financials

Revenue · 2026
₹2,319 Cr
Net profit
₹146 Cr
Margin
6%
2023
2024
2025
2026
Revenue Net profitLatest revenue YoY +12%

Shareholding

  • Promoter67.0%
  • Institutions1.3%
  • Public & other31.7%

Promoter holding via insider stake; institutional via reported holdings.

Key fundamentals

Market cap
₹3,844 Cr
P/E ratio
28.0
P/B ratio
2.14
EPS (TTM)
₹4.68
ROE
7.9%
Debt / Equity
0.08x
Profit margin
5.9%
Free cash flow
₹-3 Cr
52-week high
₹220.22
-12.91% from high
52-week low
₹68.15
Dividend yield
0.8%
Beta
0.43
SWOT snapshot

Bull case vs bear case

Bull case

Strengths

  • Lightly leveraged balance sheet.
  • Financially solid — Altman Z 4.83.

Opportunities

  • Earnings growing (70% YoY).
  • Revenue growing (17% YoY).
  • Trading in our value buy zone versus sector peers.

Bear case

Weaknesses

  • Low return on equity (7.9%).

About IOL Chemicals and Pharmaceuticals Limited

IOL Chemicals and Pharmaceuticals manufactures pharmaceutical and chemical products for domestic and international markets across two segments. Its Chemical segment produces ethyl acetate, isobutyl benzene, acetyl chloride, monochloroacetic acid, and acetic anhydride for use in food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries.

IOL Chemicals and Pharmaceuticals Limited — frequently asked questions

Is IOL Chemicals and Pharmaceuticals Limited a buy, hold or sell?

TickerMagic currently rates IOL Chemicals and Pharmaceuticals Limited (IOLCP) a Buy, based on a blended score of 70/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.

What is IOL Chemicals and Pharmaceuticals Limited's fair value?

Our blended DCF and relative-valuation model estimates IOL Chemicals and Pharmaceuticals Limited's fair value at about ₹222.15, versus a current price of ₹191.78 — roughly 16% upside. On that basis the stock looks undervalued by 16%.

Is IOL Chemicals and Pharmaceuticals Limited financially healthy?

IOL Chemicals and Pharmaceuticals Limited scores 96/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9.

How has IOL Chemicals and Pharmaceuticals Limited's share price performed?

IOL Chemicals and Pharmaceuticals Limited is up 20% over three months, and last traded at ₹191.78. Past performance doesn't predict future returns.

Our verdict, fair value, financial-health and checklist are TickerMagic's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.